A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.

BACKGROUND:Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cle...

Full description

Bibliographic Details
Main Authors: Michèle Vasseur, Nicolas Simon, Chloé Picher, Camille Richeval, Marion Soichot, Luc Humbert, Christine Barthélémy, Sandrine Fleury-Souverain, Pascal Bonnabry, Bertrand Décaudin, Delphine Allorge, Pascal Odou
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6082556?pdf=render
id doaj-8fbe8420affb4824bdde18b8510dc4d2
record_format Article
spelling doaj-8fbe8420affb4824bdde18b8510dc4d22020-11-24T21:35:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e020133510.1371/journal.pone.0201335A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.Michèle VasseurNicolas SimonChloé PicherCamille RichevalMarion SoichotLuc HumbertChristine BarthélémySandrine Fleury-SouverainPascal BonnabryBertrand DécaudinDelphine AllorgePascal OdouBACKGROUND:Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cleaning procedure + specific decontamination procedure. METHODS AND FINDINGS:A comparative and prospective study was carried out in a newly opened compounding unit. Compounding was performed with a CSTD (BD-Phaseal, Becton-Dickinson). In the Control isolator (C), the cleaning process was completed daily with a standard biocide solution (AnioxysprayTM, Anios, France). In the Intervention isolator (I), weekly decontamination with a homemade admixture of sodium dodecyl sulfate 10(-2) M/70% isopropanol (80/20, v/v) was added. Monitoring was performed via a validated LC-MS/MS method. Eight drugs (cyclophosphamide, cytarabine, dacarbazine, fluorouracile, gemcitabine, ifosfamide, irinotecan and methotrexate) were monitored daily over 14 consecutive weeks on three sites inside the isolators: gloves, workbench and window. Results are presented as the odds-ratio (OR) of contamination and as overall decontamination efficiency (EffQ, %). The proportion of EffQ ≥ 90% was assessed by a Fisher's exact test (p<0.05). Overall contamination rates (CR, %) were significantly different from one isolator to the other (CRC = 25.3% vs. CRI = 10.4%; OR = 0.341; p<0.0001). Overall EffQ values (median; 1st and 3rd quartiles) were higher in the intervention isolator (I: 78.3% [34.6%;92.6%] vs. C: 59.5% [-5.5%;72.6%]; p = 0.0015) as well as the proportion of days with an EffQ ≥ 90% (I: 42.9% vs. C: 7.1%; p = 0.077) but very variable depending on drugs. CONCLUSION:Adding a decontamination protocol with a tensioactive agent to a CSTD leads to better control of chemical contamination inside isolators. Improving decontamination by increasing decontamination frequency or modifying the protocol will be further studied.http://europepmc.org/articles/PMC6082556?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Michèle Vasseur
Nicolas Simon
Chloé Picher
Camille Richeval
Marion Soichot
Luc Humbert
Christine Barthélémy
Sandrine Fleury-Souverain
Pascal Bonnabry
Bertrand Décaudin
Delphine Allorge
Pascal Odou
spellingShingle Michèle Vasseur
Nicolas Simon
Chloé Picher
Camille Richeval
Marion Soichot
Luc Humbert
Christine Barthélémy
Sandrine Fleury-Souverain
Pascal Bonnabry
Bertrand Décaudin
Delphine Allorge
Pascal Odou
A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.
PLoS ONE
author_facet Michèle Vasseur
Nicolas Simon
Chloé Picher
Camille Richeval
Marion Soichot
Luc Humbert
Christine Barthélémy
Sandrine Fleury-Souverain
Pascal Bonnabry
Bertrand Décaudin
Delphine Allorge
Pascal Odou
author_sort Michèle Vasseur
title A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.
title_short A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.
title_full A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.
title_fullStr A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.
title_full_unstemmed A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.
title_sort decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. a prospective, parallel study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description BACKGROUND:Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cleaning procedure + specific decontamination procedure. METHODS AND FINDINGS:A comparative and prospective study was carried out in a newly opened compounding unit. Compounding was performed with a CSTD (BD-Phaseal, Becton-Dickinson). In the Control isolator (C), the cleaning process was completed daily with a standard biocide solution (AnioxysprayTM, Anios, France). In the Intervention isolator (I), weekly decontamination with a homemade admixture of sodium dodecyl sulfate 10(-2) M/70% isopropanol (80/20, v/v) was added. Monitoring was performed via a validated LC-MS/MS method. Eight drugs (cyclophosphamide, cytarabine, dacarbazine, fluorouracile, gemcitabine, ifosfamide, irinotecan and methotrexate) were monitored daily over 14 consecutive weeks on three sites inside the isolators: gloves, workbench and window. Results are presented as the odds-ratio (OR) of contamination and as overall decontamination efficiency (EffQ, %). The proportion of EffQ ≥ 90% was assessed by a Fisher's exact test (p<0.05). Overall contamination rates (CR, %) were significantly different from one isolator to the other (CRC = 25.3% vs. CRI = 10.4%; OR = 0.341; p<0.0001). Overall EffQ values (median; 1st and 3rd quartiles) were higher in the intervention isolator (I: 78.3% [34.6%;92.6%] vs. C: 59.5% [-5.5%;72.6%]; p = 0.0015) as well as the proportion of days with an EffQ ≥ 90% (I: 42.9% vs. C: 7.1%; p = 0.077) but very variable depending on drugs. CONCLUSION:Adding a decontamination protocol with a tensioactive agent to a CSTD leads to better control of chemical contamination inside isolators. Improving decontamination by increasing decontamination frequency or modifying the protocol will be further studied.
url http://europepmc.org/articles/PMC6082556?pdf=render
work_keys_str_mv AT michelevasseur adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT nicolassimon adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT chloepicher adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT camillericheval adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT marionsoichot adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT luchumbert adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT christinebarthelemy adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT sandrinefleurysouverain adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT pascalbonnabry adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT bertranddecaudin adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT delphineallorge adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT pascalodou adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT michelevasseur decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT nicolassimon decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT chloepicher decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT camillericheval decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT marionsoichot decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT luchumbert decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT christinebarthelemy decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT sandrinefleurysouverain decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT pascalbonnabry decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT bertranddecaudin decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT delphineallorge decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT pascalodou decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
_version_ 1725945695813238784